Hans‐Theodor Eich

27 papers receiving 752 citations

Hans‐Theodor Eich's Hit Papers

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial 2024 · 65 citations
650+1Years since publication204060

Peers

Hans‐Theodor Eich
Comparison fields: 5 of 48
  • Pathology and Forensic Medicine 488
  • Otorhinolaryngology 72
  • Neurology 171
  • Genetics 89
  • Oncology 214
Replace Yoshio Tamaki with:
Yoshio Tamaki Japan
M. Tao Singapore
Ari Ballonoff United States
G.M. Mead United Kingdom
Simone Snijder Netherlands
Lucio Babini Italy
Árpád Szomor Hungary
Ahitagni Biswas India
Pierre Yves Dietrich Switzerland
Christine F. Wogan United States
Hans‐Theodor Eich relative to Yoshio Tamaki Japan Yoshio Tamaki's profile →
Citations per field
00.5×2×4×6×8.5×
Yoshio Tamaki · 1×
Citations per year

Countries citing papers authored by Hans‐Theodor Eich

Since Specialization
Citations

This map shows the geographic impact of Hans‐Theodor Eich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans‐Theodor Eich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans‐Theodor Eich more than expected).

Fields of papers citing papers by Hans‐Theodor Eich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans‐Theodor Eich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans‐Theodor Eich. The network helps show where Hans‐Theodor Eich may publish in the future.

Co-authors

The 25 scholars most cited alongside Hans‐Theodor Eich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hans‐Theodor Eich Line = papers co-authored together Hans‐Theodor Eich links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011149
2 2004118
3
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Hit paper breakdown →
202465
4 201450
5 201149
6 200543
7 201139
8 201238
9 201832
10 201129
11 201029
12 200527
13 200518
14 201017
15 202313
16 200311
17 201211
18 20239
19 20017
20 20236

About Hans‐Theodor Eich

Hans‐Theodor Eich is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Dermatology and Radiation, having authored 31 papers that have together received 775 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Lung Cancer Treatments and Mutations (11 papers), Head and Neck Cancer Studies (4 papers), Advanced Radiotherapy Techniques (3 papers), Cutaneous lymphoproliferative disorders research (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Medical Imaging Techniques and Applications (2 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (488 citations), Otorhinolaryngology (72 citations), Neurology (171 citations), Genetics (89 citations) and Oncology (214 citations). Hans‐Theodor Eich has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Joachim E. Zöller, Uta Drebber, Martin Scheer, Matthias Kreppel, Volker Diehl, Andreas Engert, Rolf‐Peter Müller, Heinz Haverkamp, Jana Marková and Robert Semrau. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Journal of Clinical Oncology, Strahlentherapie und Onkologie, Blood and Annals of Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact